JRMS-Journal of Research in Medical Sciences. 2005; 10 (4): 205-209
Dans Anglais
| IMEMR
| ID: emr-72856
ABSTRACT
Iron deficiency and its resulting anemia is a common problem among Iranian pregnant women. In spite of iron supplementation program, yet, this problem has not resolved in many parts of the country. Zinc deficiency also is very common in Iran. This study evaluated the efficiency of concomitant zinc and iron therapy in the treatment of anemic pregnant Iranian women. A total of 118 anemic women were registered in this randomized controlled trial. Both groups received 100 mg elemental iron daily. The intervention group received an additional dose of 15mg zinc every day for a period of 12 weeks while the control group received placebo. Serum hemoglobin was measured at the beginig of study, after 12 weeks of treatment and at the end of 8 weeks follow-up. Collected data were analyzed with%95 significance level by ANOVA test for comparing baseline characteristics in the two groups and t-test was applied to assess hemoglobin changes in the intervention group. After 12 weeks of therapy, desirable response was obtained in 78.35% and 93.1% [CI=95%] of anemic women in control and intervention group, respectively which showed a significant difference [P<001]. this study clearly demonstrated the efficacy of this inexpensive and simple intervention in the treatment of anemia and prevention of its recurrence in anemic pregnant women
Recherche sur Google
Indice:
Méditerranée orientale
Sujet Principal:
Complications hématologiques de la grossesse
/
Grossesse
/
Composés du fer II
/
Anémie par carence en fer
/
Sulfate de zinc
/
Association de médicaments
Type d'étude:
Essai clinique contrôlé
Limites du sujet:
Femelle
/
Humains
langue:
Anglais
Texte intégral:
J. Res. Med. Sci.
Année:
2005
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS